AuBuchon J P
Department of Pathology, Darthmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA.
Clin Lab Med. 1996 Dec;16(4):797-816.
Although platelet transfusion is a vital part of modern hemotherapy, many related issues are unresolved. The most appropriate trigger point of transfusion and the clinical utility of prophylactic transfusion are still debated, but the importance of patient-specific transfusion decisions is clear. Leukocyte reduction and single donor platelets may have important roles in avoiding complications, but more data are needed. Establishment of a standardized protocol for managing patients receiving ongoing platelet transfusions may facilitate application of special techniques and the use of specially chosen units that provide better platelet support for thrombocytopenic patients.
尽管血小板输注是现代血液治疗的重要组成部分，但许多相关问题仍未得到解决。最适宜的输血触发点以及预防性输血的临床效用仍存在争议，但针对患者的个体化输血决策的重要性是明确的。白细胞去除和单采血小板在避免并发症方面可能具有重要作用，但仍需要更多数据。建立针对接受持续血小板输注患者的标准化管理方案，可能有助于特殊技术的应用以及选择能为血小板减少症患者提供更好血小板支持的特定单位。
